Pro Share Advisors LLC Adverum Biotechnologies, Inc. Transaction History

Pro Share Advisors LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.81 - $1.34 $21,419 - $35,434	-26,444 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$1.23 - $1.95 $7,820 - $12,398	-6,358 Reduced 19.38%	26,444 $34,000
Q4 2021 Feb 08, 2022	BUY	$1.74 - $2.4 $1,231 - $1,699	708 Added 2.21%	32,802 $57,000
Q3 2021 Nov 12, 2021	SELL	$2.08 - $3.6 $16,721 - $28,940	-8,039 Reduced 20.03%	32,094 $70,000
Q2 2021 Aug 13, 2021	BUY	$3.36 - $10.56 $9,599 - $30,169	2,857 Added 7.66%	40,133 $140,000
Q1 2021 May 14, 2021	BUY	$9.26 - $14.36 $23,325 - $36,172	2,519 Added 7.25%	37,276 $368,000
Q4 2020 Feb 09, 2021	BUY	$9.84 - $14.26 $86,434 - $125,259	8,784 Added 33.82%	34,757 $377,000
Q3 2020 Nov 13, 2020	BUY	$10.3 - $21.64 $33,145 - $69,637	3,218 Added 14.14%	25,973 $268,000
Q2 2020 Aug 03, 2020	BUY	$8.53 - $25.64 $87,483 - $262,963	10,256 Added 82.05%	22,755 $475,000
Q1 2020 May 15, 2020	SELL	$7.98 - $16.32 $70,104 - $143,371	-8,785 Reduced 41.28%	12,499 $122,000
Q4 2019 Feb 12, 2020	SELL	$5.12 - $12.22 $11,857 - $28,301	-2,316 Reduced 9.81%	21,284 $245,000
Q3 2019 Nov 12, 2019	SELL	$5.24 - $15.89 $3,563 - $10,805	-680 Reduced 2.8%	23,600 $129,000
Q2 2019 Aug 13, 2019	SELL	$5.1 - $11.89 $15,279 - $35,622	-2,996 Reduced 10.98%	24,280 $289,000
Q1 2019 May 15, 2019	BUY	$3.03 - $6.02 $696 - $1,384	230 Added 0.85%	27,276 $143,000
Q4 2018 Feb 14, 2019	BUY	$2.87 - $5.92 $77,622 - $160,112	27,046 New	27,046 $85,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.